IDSA's updated guidelines on COVID-19 released
Infectious Disease Society of America (IDSA) has been releasing new approach and recommendation for managing COVID-19 at regular intervals. It has now released new updates on the treatment and management of patients with COVID-19.
New updates of Infectious Disease Society of America (IDSA) guidelines include recommendations on the routine use of lopinavir/ritonavir, tocilizumab, and remdesivir. It also includes a new recommendation for the use of Bamlanivimab. The updated versions were released on 18/11/2020 and 22/11/2020.